Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Cancer Research
|
February 11, 1998
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma
E D Bischoff, M M Gottardis, T E Moon, et al.
Cancer Research
|
December 15, 1996
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand
M M Gottardis, E D Bischoff, M A Shirley, et al.
Ernst Schering Research Foundation Workshop
|
January 14, 2005
Precursor-directed biosynthesis for the generation of novel glycopetides
E Stegmann, D Bischoff, C Kittel, et al.
Journal of Lipid Research
|
April 15, 2010
Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice
Eric D Bischoff, Chris L Daige, Mary Petrowski, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 25, 2000
Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma
S D Gamage, E D Bischoff, K D Burroughs, et al.
The Journal of Biological Chemistry
|
May 20, 2003
Farnesoid X receptor regulates bile acid-amino acid conjugation
Parinaz C Pircher, Jennifer L Kitto, Mary L Petrowski, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 13, 2004
Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists
Nancy Levin, Eric D Bischoff, Chris L Daige, et al.
Cancer Research
|
January 1, 1997
A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice
D R Shalinsky, E D Bischoff, W W Lamph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice
D R Shalinsky, E D Bischoff, M L Gregory, et al.
Amino Acids
|
February 9, 2007
Nano-structured support materials, their characterisation and serum protein profiling through MALDI/TOF-MS
M Najam-Ul-Haq, M Rainer, N Heigl, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Cancer Research
|
February 11, 1998
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma
E D Bischoff, M M Gottardis, T E Moon, et al.
Cancer Research
|
December 15, 1996
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand
M M Gottardis, E D Bischoff, M A Shirley, et al.
Ernst Schering Research Foundation Workshop
|
January 14, 2005
Precursor-directed biosynthesis for the generation of novel glycopetides
E Stegmann, D Bischoff, C Kittel, et al.
Journal of Lipid Research
|
April 15, 2010
Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice
Eric D Bischoff, Chris L Daige, Mary Petrowski, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 25, 2000
Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma
S D Gamage, E D Bischoff, K D Burroughs, et al.
The Journal of Biological Chemistry
|
May 20, 2003
Farnesoid X receptor regulates bile acid-amino acid conjugation
Parinaz C Pircher, Jennifer L Kitto, Mary L Petrowski, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 13, 2004
Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists
Nancy Levin, Eric D Bischoff, Chris L Daige, et al.
Cancer Research
|
January 1, 1997
A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice
D R Shalinsky, E D Bischoff, W W Lamph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice
D R Shalinsky, E D Bischoff, M L Gregory, et al.
Amino Acids
|
February 9, 2007
Nano-structured support materials, their characterisation and serum protein profiling through MALDI/TOF-MS
M Najam-Ul-Haq, M Rainer, N Heigl, et al.
Page
of 3